Current Neuropharmacology
Title:EDITORIAL: New Psychoactive Substances (NPS), a New Global Issue: Neuropharmacological, Chemical and Toxicological Aspects
Volume: 15 Issue: 5
Author(s): Simona Pichini, Francesco P. Busardo, Roberta Pacifici and Pascal Kintz
Affiliation:
Export Options
About this article
Cite this article as:
Pichini Simona, Busardo P. Francesco, Pacifici Roberta and Kintz Pascal, EDITORIAL: New Psychoactive Substances (NPS), a New Global Issue: Neuropharmacological, Chemical and Toxicological Aspects, Current Neuropharmacology 2017; 15 (5) . https://dx.doi.org/10.2174/1570159X14666161220154550
DOI https://dx.doi.org/10.2174/1570159X14666161220154550 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Role of Infections in the Pathogenesis of Autoimmune Diseases
Current Drug Targets - Inflammation & Allergy Gene Therapy to Improve High-Density Lipoprotein Metabolism and Function
Current Pharmaceutical Design Biochemical and Clinical Aspects of the Human Flavin-Containing Monooxygenase Form 3 (FMO3) Related to Trimethylaminuria
Current Drug Metabolism Subject Index To Volume 7
Current Pharmaceutical Biotechnology Who Should Receive Low-Dose Aspirin for Pre-eclampsia Prevention? Sorting through the Meta-Analyses
Current Women`s Health Reviews Biochemical Micro-Techniques in the Diagnosis and Classification of Amyloidosis
Current Pharmaceutical Analysis From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases
Current Drug Targets - CNS & Neurological Disorders Mucoadhesive Polymers for Delivery of Drugs to the Oral Cavity
Recent Patents on Drug Delivery & Formulation Gonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration
CNS & Neurological Disorders - Drug Targets Does Anorexia Nervosa Resemble an Addiction?
Current Drug Abuse Reviews Xanthone Derivatives: New Insights in Biological Activities
Current Medicinal Chemistry Development of Tamper Deterrent Formulations: State of the Pharmaceutical Industry
Current Drug Abuse Reviews Designing Phage Therapeutics
Current Pharmaceutical Biotechnology Evaluation of the Antidepressant Like Activity of Ethanolic Extract of Calendula officinalis using Rodent Models (Wistar Rat) of Depression
Current Psychopharmacology The Quinoline Imidoselenocarbamate EI201 Blocks the AKT/mTOR Pathway and Targets Cancer Stem Cells Leading to a Strong Antitumor Activity
Current Medicinal Chemistry Cannabinoid Hyperemesis Syndrome
Current Drug Abuse Reviews Platelet Toll-Like Receptor Expression: The Link Between “Danger” Ligands and Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
CNS & Neurological Disorders - Drug Targets Methods to Access 2-aminobenzimidazoles of Medicinal Importance
Current Organic Chemistry Pharmacological Interventions to Attenuate Alzheimer’s Disease Progression: The Story So Far
Current Alzheimer Research